Clearstead Advisors’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-747
Closed -$3.73K 2629
2025
Q4
$3.73K Sell
747
-6,511
-90% -$33.9K ﹤0.01% 2074
2025
Q3
$36.8K Buy
+7,258
New +$32K ﹤0.01% 1389
2025
Q2
Sell
-383
Closed -$2.31K 2825
2025
Q1
$2.31K Buy
+383
New +$1.94K ﹤0.01% 1879
2024
Q2
Sell
-362
Closed -$2.02K 2053
2024
Q1
$2.02K Buy
+362
New +$1.39K ﹤0.01% 1307
2022
Q1
Sell
-891
Closed -$21K 1431
2021
Q4
$21K Hold
891
﹤0.01% 818
2021
Q3
$18K Buy
+891
New +$18.3K ﹤0.01% 846

Other funds holding MPT

Clearstead Advisors's MPT Position: Q1 2026 in Review

Clearstead Advisors sold out of Medical Properties Trust (MPT) in Q1 2026, closing a stake of 747 shares — an estimated $3.73K sold.

Clearstead Advisors first reported a position in MPT in Q3 2021 and held it in 6 quarters. The position peaked at $36.8K in Q3 2025. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • Clearstead Advisors reported no remaining Medical Properties Trust position as of Q1 2026 after selling out during the quarter.
  • Clearstead Advisors sold 747 Medical Properties Trust shares in Q1 2026, an estimated $3.73K.
  • Clearstead Advisors first reported a position in Medical Properties Trust in Q3 2021 and held it in 6 quarters.
  • Clearstead Advisors's Medical Properties Trust position peaked at $36.8K in Q3 2025.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on Clearstead Advisors's 13F filing for Q1 2026, filed 6 May 2026.